These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. Meek TD, Dayton BD, Metcalf BW, Dreyer GB, Strickler JE, Gorniak JG, Rosenberg M, Moore ML, Magaard VW, Debouck C. Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1841-5. PubMed ID: 2648384 [Abstract] [Full Text] [Related]
44. Purification and characterization of the mouse mammary tumor virus protease expressed in Escherichia coli. Menéndez-Arias L, Young M, Oroszlan S. J Biol Chem; 1992 Nov 25; 267(33):24134-9. PubMed ID: 1331110 [Abstract] [Full Text] [Related]
45. Unique precursor structure of an extracellular protease, aqualysin I, with NH2- and COOH-terminal pro-sequences and its processing in Escherichia coli. Terada I, Kwon ST, Miyata Y, Matsuzawa H, Ohta T. J Biol Chem; 1990 Apr 25; 265(12):6576-81. PubMed ID: 2182621 [Abstract] [Full Text] [Related]
46. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant. Moody MD, Pettit SC, Shao W, Everitt L, Loeb DD, Hutchison CA, Swanstrom R. Virology; 1995 Mar 10; 207(2):475-85. PubMed ID: 7886951 [Abstract] [Full Text] [Related]
47. Crystallizable HIV-1 protease derived from expression of the viral pol gene in Escherichia coli. Danley DE, Geoghegan KF, Scheld KG, Lee SE, Merson JR, Hawrylik SJ, Rickett GA, Ammirati MJ, Hobart PM. Biochem Biophys Res Commun; 1989 Dec 29; 165(3):1043-50. PubMed ID: 2692557 [Abstract] [Full Text] [Related]
48. Expression, purification, and characterization of the yeast KEX1 gene product, a polypeptide precursor processing carboxypeptidase. Latchinian-Sadek L, Thomas DY. J Biol Chem; 1993 Jan 05; 268(1):534-40. PubMed ID: 8416959 [Abstract] [Full Text] [Related]
50. Purification, assay and kinetic features of HIV-1 proteinase. Billich A, Hammerschmid F, Winkler G. Biol Chem Hoppe Seyler; 1990 Mar 05; 371(3):265-72. PubMed ID: 2187485 [Abstract] [Full Text] [Related]
52. Peptide substrate cleavage specificity of the human cytomegalovirus protease. Sardana VV, Wolfgang JA, Veloski CA, Long WJ, LeGrow K, Wolanski B, Emini EA, LaFemina RL. J Biol Chem; 1994 May 20; 269(20):14337-40. PubMed ID: 8182034 [Abstract] [Full Text] [Related]
53. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles. Chiu HC, Yao SY, Wang CT. J Virol; 2002 Apr 20; 76(7):3221-31. PubMed ID: 11884546 [Abstract] [Full Text] [Related]
54. Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. Weaver TA, Talbot KJ, Panganiban AT. J Virol; 1990 Jun 20; 64(6):2642-52. PubMed ID: 2186174 [Abstract] [Full Text] [Related]
55. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. Tritch RJ, Cheng YE, Yin FH, Erickson-Viitanen S. J Virol; 1991 Feb 20; 65(2):922-30. PubMed ID: 1987379 [Abstract] [Full Text] [Related]
56. Herpes simplex virus type 1 protease expressed in Escherichia coli exhibits autoprocessing and specific cleavage of the ICP35 assembly protein. Deckman IC, Hagen M, McCann PJ. J Virol; 1992 Dec 20; 66(12):7362-7. PubMed ID: 1331526 [Abstract] [Full Text] [Related]
57. Expression of human T-cell leukemia virus type I protease in Escherichia coli. Hayakawa T, Misumi Y, Kobayashi M, Ohi Y, Fujisawa Y, Kakinuma A, Hatanaka M. Biochem Biophys Res Commun; 1991 Dec 31; 181(3):1281-7. PubMed ID: 1764078 [Abstract] [Full Text] [Related]
58. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles. Wu X, Liu H, Xiao H, Conway JA, Kappes JC. J Virol; 1996 Jun 31; 70(6):3378-84. PubMed ID: 8648668 [Abstract] [Full Text] [Related]
59. Molecular structure of Rarobacter faecitabidus protease I. A yeast-lytic serine protease having mannose-binding activity. Shimoi H, Iimura Y, Obata T, Tadenuma M. J Biol Chem; 1992 Dec 15; 267(35):25189-95. PubMed ID: 1339445 [Abstract] [Full Text] [Related]
60. Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. Rosé JR, Babé LM, Craik CS. J Virol; 1995 May 15; 69(5):2751-8. PubMed ID: 7535864 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]